How do these agencies ensure the safety and efficacy of cancer treatments?
Agencies like the FDA and EMA require extensive clinical trials to be conducted before a new treatment can be approved. These trials are divided into phases: Phase I tests safety, Phase II assesses efficacy and side effects, and Phase III compares the new treatment to existing standards. Post-market surveillance continues to monitor safety and effectiveness.
